Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission

Bullous pemphigoid

A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (BALLAD) Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) Telederm and Bullous Pemphigoid Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid Efficacy and Safety of Ustekinumab in Bullous Pemphigoid Ixekizumab in the Treatment of Bullous Pemphigoid Rituximab in the Treatment of Patients With Bullous Pemphigoid Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid Efficacy and Safety of Omalizumab in Bullous Pemphigoid Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid? Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid